Upregulation of T‐cell factor‐4 isoform‐responsive target genes in hepatocellular carcinoma

Liver International - Tập 33 Số 7 - Trang 1100-1112 - 2013
Yoshito Tomimaru1, Hironori Koga2, Hirohisa Yano3, Suzanne de la Monte4, Jack R. Wands1, Miran Kim1
1Liver Research Center, Rhode Island Hospital, the Warren Alpert Medical School of Brown University, Providence, RI, USA
2Division of Gastroenterology, Department of Medicine, Kurume University of School of Medicine, Kurume, Japan
3Department of Pathology, Kurume University of School of Medicine, Kurume, Japan
4Department of Pathology, the Warren Alpert Medical School of Brown University, Providence, RI, USA

Tóm tắt

AbstractBackgroundThe Wnt/β‐catenin signalling pathway regulates genes involved in cell proliferation, survival, migration and invasion through regulation by T‐cell factor (TCF)‐4 transcription factor proteins. However, the role ofTCF‐4 isoforms generated by alternative splicing events in hepatocellular carcinoma (HCC) is unknown.AimHere, we investigatedTCF‐4 isoforms (TCF‐4J and K)‐responsive target genes that are important in hepatic oncogenesis and tumour development.MethodsGene expression microarray was performed onHCCcells overexpressingTCF‐4J and K isoforms. Expression level of selected target genes was evaluated and correlations were made between their expression level and that ofTCF‐4 isoform in 47 pairs of humanHCCtumours.ResultsComparison by gene expression microarray revealed that 447 genes were upregulated and 343 downregulated more than 2.0‐fold inTCF‐4J compared withTCF‐4K expressing cells. We validated expression of 18 selected target genes involved in Wnt/β‐catenin, insulin/IGF‐1/IRS1 and Notch signalling pathways in 47 pairs of humanHCCs and adjacent uninvolved liver tissues. It was observed that 13 genes (CLDN2,STK17B,SPP1,AXIN2,WISP2,MMP7,IRS1,ANXA1,CAMK2N1,ASPH,GPR56,CD24 andJAG1) activated byTCF‐4J isoform inHCCcells, were also upregulated inHCCtumours compared with adjacent peritumour tissue; more importantly, 10 genes exhibited a significant correlation with theTCF‐4J expression level in tumour.ConclusionTCF‐4 isoforms (TCF‐4J and K) activated different downstream target genes inHCC. The biological consequence ofTCF‐4J isoform expression was upregulation of genes associated with tripartite Wnt/β‐catenin, insulin/IGF‐1/IRS1 and Notch signal transduction pathway activation, which contribute to the pathogenesis ofHCC.

Từ khóa


Tài liệu tham khảo

10.1016/j.cell.2006.10.018

10.4161/epi.4.5.9371

10.1053/j.gastro.2007.04.061

10.1038/sj.bjc.6604422

10.1016/j.jhep.2007.12.020

10.1016/j.semcancer.2010.12.010

10.1038/73448

10.1038/sj.onc.1210059

10.1016/j.yexcr.2011.01.015

10.1371/journal.pone.0039981

10.1073/pnas.0702387104

10.1002/hep.20286

10.1158/0008-5472.CAN-06-2344

10.1007/BF02619623

10.1002/hep.1840180216

10.1172/JCI118918

10.1111/j.1440-1746.2012.07256.x

Cohen J, 1988, Statistical power analysis for the behavioral sciences

10.1002/hep.22856

10.1016/j.bbrc.2003.12.185

Kinugasa T, 2007, Selective up‐regulation of claudin‐1 and claudin‐2 in colorectal cancer, Anticancer Res, 27, 3729

Brown LF, 1994, Osteopontin expression and distribution in human carcinomas, Am J Pathol, 145, 610

10.1016/j.jhep.2010.06.030

10.1111/j.1349-7006.2011.01981.x

10.1074/jbc.M109.060319

10.1016/j.jhep.2006.01.038

10.1002/hep.21272

10.1002/hep.23650

JR Wands M Kim 2011 Springer Scientific New York 103 27

10.1093/carcin/bgn113

El‐Tanani M, 2001, Metastasis‐inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf‐4, Cancer Res, 61, 5619

10.1073/pnas.0813221106

10.1074/jbc.M206402200

10.1128/MCB.22.4.1172-1183.2002

10.1007/978-1-59745-249-6_9

10.1007/s10555-012-9373-9

10.2174/138920111798377058

10.1016/j.ccr.2005.06.004

10.1038/ncb2048

Jesse S, 2009, Lef‐1 isoforms regulate different target genes and reduce cellular adhesion, Int J Cancer, 126, 1109, 10.1002/ijc.24802

10.1002/hep.21196

10.2741/1933

10.1038/nm1377

10.1002/hep.21467

10.1158/0008-5472.CAN-08-0742

10.1158/0008-5472.CAN-09-1089

10.1038/nm843

10.1016/j.jhep.2010.06.033

10.1038/sj.bjc.6605144

10.1038/bjc.2011.269

10.3109/07357907.2010.543211

10.1016/S0014-4827(03)00310-0

10.1074/jbc.M800436200

10.1186/1476-4598-3-15

10.1007/978-1-4419-7913-1_8

10.1038/sj.onc.1209470

Fujimoto T, 2009, SiRNA of frizzled‐9 suppresses proliferation and motility of hepatoma cells, Int J Oncol, 35, 861

10.1053/j.gastro.2008.03.024

10.1016/j.brainresbull.2011.09.020